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Abstract 
The emerging discipline of evolutionary medicine is breaking new ground in understanding 
why people get sick. However, the value of evolutionary analyses of human physiology and 
behaviour is only beginning to be recognized in the field of public health. Core principles 
come from life history theory, which analyses the allocation of finite amounts of energy 
among four competing functions – maintenance, growth, reproduction and defence. A 
central tenet of evolutionary theory is that organisms are selected to allocate energy and 
time to maximize reproductive success, rather than health or longevity. Ecological 
interactions that influence mortality risk, nutrient availability and pathogen burden shape 
energy-allocation strategies throughout the life-course, thereby impacting diverse health 
outcomes. Public health interventions could improve their efficacy by incorporating an 
evolutionary perspective. In particular, evolutionary approaches offer new opportunities to 
address the complex challenges of global health, where populations are differentially 
exposed to the metabolic consequences of poverty, high fertility, infectious diseases, and 
rapid changes in nutrition and lifestyle. The impact of specific interventions may depend on 
broader factors shaping life expectancy. Amongst the important tools in this approach are 
mathematical models, which can explore likely benefits and limitations of interventions in 
silico, prior to their implementation in human populations. 
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Introduction 
 
Public health aims to prevent disease, promote health and prolong life among human 
populations through the organized efforts of society.1,2 It is intuitive that improving living 
conditions should benefit health, but from an evolutionary perspective this assumption is 
simplistic. Natural selection has not shaped organisms for maximum health, but rather to 
maximize their reproductive success (‘genetic fitness’, see supplementary online glossary). 
Consequently, public health interventions may not always achieve exactly what they 
intended. 
 
Consider an example from rural Ethiopia, where a water development scheme aimed to 
decrease the daily energy burden on women who carried water up to 30 km in clay pots.3 By 
reducing this stress, while energy supply remained unchanged, one might anticipate 
improved maternal nutritional status, transmitting health benefits to the next generation. 
But the outcome was different: a pioneering evolutionary analysis by Gibson and Mace 
concluded that the ‘energy saved’ by the installation of village water taps enhanced 
maternal fertility, which was associated with worsening childhood malnutrition. They 
suggested that the outcome might have been better if the intervention had included a family 
planning component. 
 
This example highlights the potential benefits of an evolutionary perspective in public health. 
Human physiology and behaviour have been selected to transmit genes to future 
generations. Health is sometimes compromised in favour of immediate survival or 
reproduction, and particularly so under conditions of deprivation and environmental 
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harshness. Public health has benefitted substantially from incorporating a life-course 
perspective, capable of integrating the impacts of physical, biological and societal stresses or 
stimuli at different life stages.4-7 Evolutionary approaches could extend these benefits, 
providing new insight into the health-consequences of efforts to change behaviour patterns 
or the environment.  
 
In 1973, Dobzhansky observed that ‘nothing in biology makes sense except in the light of 
evolution’.8 Through the 20th century, evolutionary approaches permeated most areas of 
biological enquiry, and are increasingly employed by policy makers in agriculture and 
fisheries management.9-11 Surprisingly, however, an evolutionary perspective on medicine 
only emerged recently. 
 
A key benefit is the availability of solid overarching theory. Most natural sciences have a 
strong theoretical basis, e.g. quantum theory in physics, molecular theory in chemistry.12 
Evolution is also a ‘basic science’,13 and it is no exaggeration to suggest that its application in 
medicine could revolutionize the discipline. In the 19th century, for example, pre-Darwinian 
biology was mainly descriptive. Variability was well documented, but poorly understood.  
 
Medicine remains largely pre-evolutionary - excelling in description and mechanistic 
explanations, but only beginning to explain variability in disease vulnerability across 
individuals and populations. Evolutionary theory generates testable hypotheses regarding 
how organisms should respond to environmental stimuli, and these hypotheses are widely 
supported in diverse species including humans.14-17  
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To date, evolutionary medicine has primarily aimed to go beyond understanding how people 
get sick by considering why bodies are vulnerable to disease. This helps understand why 
people present at clinics, but may not help prevent illness from developing. Building on 
earlier work,18 we argue that evolutionary approaches could benefit outcomes most directly 
in the arena of public health.  
 
In particular, they may help understand the health-impact of ecological change, whether this 
relates to non-human or societal factors.  Traditionally, public health efforts targeted risk 
factors related to pathogens. To prevent disease transmission hygiene and sanitation were 
improved, as were nutrition and living conditions to promote resilience. Although pathogens 
remain a major disease source, the global burden of ill-health is shifting towards non-
communicable diseases (NCDs), where individuals’ constitution and behaviour are key to 
susceptibility and prevention.19 Whilst some overt risk factors have been identified (e.g. 
tobacco, dietary trans-fats, carcinogens), many lie nested within ‘normal lifestyles’ (e.g. 
enjoyable behaviours) or the ‘normal range’ of physiological variability (e.g. patterns of 
growth and maturation). In turn, our lifestyles are shaped by broader societal phenomena, 
connecting health with cultural and political factors.20 By shedding more light on how 
physiology and behaviour respond to such compound stresses, evolutionary approaches 
could improve societal efforts to prevent NCDs, just as they already help reduce the burden 
of infectious disease.21  
 
This article has three objectives. First, we describe two primary components of evolutionary 
theory – natural selection and population genetics, and life history theory which provides a 
predictive framework for investigating plasticity. Second, we briefly discuss the physiological 
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and behavioural mechanisms that underpin plasticity, to elucidate how our evolved biology 
responds to environmental change. Third, we show how mathematical models could help 
predict the effects of interventions prior to their implementation. Three other papers in this 
series focus in more detail on reproduction, human-microbe interactions and nutrition.22-24 
 
Evolution, heritability and genetics 
 
Darwin’s and Wallace’s theory of natural selection provided new insight into how ancestral 
environments shape contemporary biological variability.25 The theory proposed that traits 
varied, that this variability had a heritable component, and that organisms producing more 
offspring transmitted their traits with greater frequency to subsequent generations. Over 
time, a lineage acquires the genes and phenotypes of those reproducing most successfully.26 
Though simply a ‘purposeless algorithm’,27,28 natural selection shapes traits to enhance 
genetic fitness.29,30 In Darwin’s time, scientific understanding of the mechanisms of heredity 
was rudimentary. Modern genetics emerged from the rediscovery of Mendel’s work in the 
late 19th century, laying the foundation of the modern evolutionary synthesis.31 
 
That genetic variants influence disease risk is now well-established,32 prompting interest in 
gene-based ‘personalized medicine’. Concerning treatment, ethnic differences in the 
frequency of genes that influence drug metabolism have attracted attention.33,34 Looking at 
pathogens in combination with their human hosts, most clinicians will be familiar with the 
evolutionary emergence of new infectious diseases, such as HIV, Hantaviruses, SARS and 
Ebola;35 with the possibility that imperfect vaccines can make pathogens more virulent;36 
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and with the striking threats posed by the evolution of drug- or antibiotic-resistant strains of 
some pathogens.37,38  
 
Genetic variability is also relevant to public health, in particular for understanding 
population variability in physiology. For example, where malaria is prevalent it has selected 
for protective haemoglobin variations, though these may also generate health penalties such 
as high prevalences of haemoglobinopathies deriving from autosomal recessive genes in 
malaria-exposed populations.39 Importantly, high-fitness genotypes do not maximize 
pathogen defence, but rather optimize trade-offs with other biological functions,40 as 
described below. Several evolutionary theories have been proposed for ethnic genetic 
differences in NCD susceptibility (Supplementary Table 1), though the supporting evidence 
is variable. 
 
However, ~85% of human genetic variation occurs within rather than between populations. 
41 Pedigree and twin studies indicate that NCDs cluster within families,42-45 and a key aim of 
the Human Genome Project was to identify individual contributing alleles.46 As yet, the 
additive effect of common alleles, potentially favoured though selection, explains little 
variance in NCD risk. Instead, rare deleterious alleles that evolved too recently to have been 
selected out of the gene pool seem better genetic predictors of ill health.47-49 It is often 
suggested that natural selection has ceased in humans, but a more realistic scenario is that it 
has accelerated in concert with the population boom of the last 10,000 years, increasing the 
number of new mutations.50 
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Our genes clearly contribute to individual variability in disease susceptibility, while genetic 
analyses can help identify biological pathways to be targeted by pharmaceutical treatment.51 
Nevertheless, the significance of genotypes for public health is limited by our inability to 
target them directly for interventions. Genes do not change within generations, and with 
few exceptions, such as the use of pre-implantation diagnosis in assisted reproduction to 
screen out rare deleterious alleles, efforts to influence allele frequencies across generations 
are ethically unacceptable.52,53 We therefore turn to a second component of biological 
variability that is highly amenable to intervention: plasticity. 
 
Evolution and plasticity 
 
Plasticity refers to the range of phenotypes potentially elicited by the environment from a 
single genotype. Plasticity has several different dimensions including behaviour, physiology 
and development, and responses that range from the momentary to the trans-generational. 
The primary evolutionary approach to plasticity is ‘life history theory’, which aims to predict 
how developing organisms respond to environments to maximize chances of survival and 
reproduction.54,55  
 
Life history theory provides a framework for understanding how organisms make 
physiological and behavioural ‘decisions’ – though behavioural decisions need have no basis 
in conscious deliberation. Patterns of growth, maturation, reproduction and metabolism 
account for substantial variation in the risk of NCDs and diverse cancers, but the very 
‘normality’ of these traits has hindered deeper understanding of how they contribute to the 
aetiology of ill-health, and how they might be targeted by public health programmes. 
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Crucially, their associations with health outcomes may also differ substantially between 
high-income and low-/middle-income settings. Life history theory can help explain this 
complexity, and offers a holistic framework that can integrate different components of 
human health.  
 
Life history theory 
 
Life history theory was developed to predict the coordinated evolution of the traits 
contributing directly to fitness: age/size at maturation, number/size of offspring, number of 
reproductive events per life, and aging and lifespan.  It views the evolution of these traits as 
the product of interactions between (a) ‘intrinsic constraints’ and ‘trade-offs’ – features 
inherited or acquired during development – and (b) ‘extrinsic factors’ in the environment 
that affect mortality risk and resource availability.  It then considers how extrinsic factors 
shape the combination of intrinsic traits to maximize fitness.54,55 
  
Life history theory models phenotypic evolution in general. Everything in biology has both a 
mechanistic explanation that answers the question, how does this work?, and an 
evolutionary explanation that answers the questions, how did this get here and what 
maintains its state? While these questions can be considered over the long-term, to 
understand why a species has particular traits, they can also be considered within the life-
course, to understand why individual organisms respond to environmental factors in 
particular ways. Plastic responses to environmental stimuli include physiological adaptations 
implemented by homeostatic feedback loops that can react in seconds or minutes; 
acclimations (e.g. adjustments to altitude) that can react in days to weeks through changes 
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in the set-points of feedback loops; and finally, developmental plasticity, where reactions 
usually last a lifetime.56-58 
 
The medical significance of plasticity is most apparent in the ‘developmental origins of adult 
health and disease’.5,59 Variation in early-life experience has many consequences, for 
example under-nutrition in utero increases risk of NCDs in late life,5,59 delivery by C-section 
increases risk of asthma and obesity,60,61 and receiving more antibiotic treatments before 
two years increases risk of obesity and allergies.62,63  
 
While consistent with genetic theories of evolution, the predictions of life history theory 
explain much more phenotypic variation, thus justifying its simplifications. Because 
physicians and public health professionals deal with phenotypes, they can gain substantially 
from a theory that predicts phenotypic states and how they are expected to change over an 
individual’s life-course. Going beyond ‘standard care’, understanding of each individual’s on-
going life history could guide personalized decisions concerning the prevention, diagnosis, 
and treatment of disease. 
 
Trade-offs and reaction norms 
 
Two key concepts in life history theory are trade-offs and reaction norms. A trade-off occurs 
whenever a change in one trait that increases fitness is connected to a change in another 
trait that decreases fitness. The major functions involved in trade-offs are maintenance, 
growth, reproduction, and defence, in each of which energy can be invested (Supplementary 
online Figure 1). Differential investment between these functions is shaped both by 
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resource availability, and by extrinsic mortality risk, of which key components in humans 
include infectious disease, poverty/deprivation and violence/conflict. In general, organisms 
with high mortality risk invest in rapid growth and reproduction at the expense of 
maintenance and defence, in which organisms with low mortality risk invest more.  Thus the 
life histories of species occupying contrasting environments diverge, creating a continuum 
from small, ‘fast-living’ short-lived species to large, ‘slow-living’ long-lived species (Figure 1).  
 
This continuum also characterises individual variation within species, including humans. 
Natural selection has shaped individuals to respond to cues of extrinsic mortality risk and 
resource availability with phenotypic change that maximize fitness. Specific responses 
include variation in age and size at maturity, the interval between births, and investment in 
offspring.  The quality of the external environment therefore shapes the entire schedule of 
growth, maturation, reproduction and aging. This helps explain the profound variability in 
‘life tables’, describing age-specific mortality rates and life expectancies among human 
populations, highlighting ‘slower’ and ‘faster’ life history trajectories within our species 
(Supplementary online Table 2).  
 
Each individual represents a ‘bundle’ of many trade-offs. For example, the trade-off between 
reproduction and survival (maintenance/defence) shapes the rate of aging and NCD risk. 
Trade-offs are crucial for physicians and public health planners because they force us to 
recognize that we cannot change one trait without also changing others, sometimes for the 
worse. Two trade-offs especially relevant to public health, namely immune function versus 
growth, and reproduction versus longevity, are summarized in Panel 1.  
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The second key concept, the reaction norm, describes the spectrum of phenotypes produced 
by a single genotype across a range of environmental conditions. Life history theory predicts 
the evolution of reaction norms themselves, as well as the state of traits expressed in 
specific environments. This approach clarifies how nature always interacts with nurture 
during development to produce the state of the observed organism. Examples of human 
reaction norms include age and size at maturity64 and variation in inter-birth interval 
induced by changes in nutritional status (Panel 2, Figure 2). 
 
Several issues are important when applying life history theory to humans. First, our sociality 
connects the life histories of multiple individuals. Humans demonstrate ‘cooperative 
breeding’, whereby several individuals may contribute to a ‘pooled energy budget’ for 
investment in offspring.65 Sociality can also expose individuals to stresses, such as social 
hierarchy and inter-group conflict.21 Second, cultural values that influence behaviour may 
themselves evolve over time, examples including attitudes to wealth, risk, or the costs and 
benefits of raising children.66,67 ‘Cultural’ goals may be pursued at the expense of genetic 
fitness. Third, evolved behaviour need not necessarily benefit health or fitness, an example 
being the use of narcotic substances that trigger ‘reward centres’ in the brain whilst 
compromising physiological function.68  
 
One might question whether humans in affluent environments still experience trade-offs. 
Energy can be stored outside the body in material form or social relationships, or in adipose 
tissue.69,70 Yet although wealthy humans acquire energy to invest in each of growth, health 
and reproduction, subtle trade-offs are both predicted71 and observed, for example between 
family size and the growth rate of individual children.72 Similarly, while obesity might suggest 
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a surfeit of calories, it is better considered a state of ‘metabolic perturbation’, where 
perturbed insulin dynamics provoke ‘cellular starvation’.73 Finally, some trade-offs involve 
conflicts in signalling among immune cells or in gene expression networks, and are mediated 
not by energy but by information.  These exist regardless of nutritional status. 
 
The specific ‘decisions’ that constitute each individual’s life history trajectory are enacted at 
levels that include physiology and behaviour. Many of the relevant mechanisms are already 
well understood to shape disease risk. What we emphasize here is that these are the same 
mechanisms that permit adaptation through plasticity to ecological stresses. Both hormonal 
and behavioural plasticity represent mechanisms of ‘risk management’ that are inherently 
sensitive to physical and societal stimuli.70 
 
Life history plasticity and hormones 
 
Hormones allow organisms to respond to both endogenous and exogenous environmental 
factors by modifying cell functions variably across tissues and organs.74 Hormones are now 
recognized to generate multiple physiological effects, a scenario known as pleiotropy.74  
 
For example, insulin plays a key role in allocating energy across competing physiological 
functions. Conventionally, clinicians think of insulin as responsible for regulating blood 
glucose, and variability in its production or activity is central to the constellation of diseases 
grouped as diabetes.75 However, its total metabolic profile is far more complex, and it 
affects diverse functions in tissue-specific ways.76 Via receptors in the brain, insulin 
modulates the regulation of peripheral metabolism, including appetite, reproductive 
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function, thermoregulation and adiposity.76,77 Within the brain, insulin also regulates 
cognitive functions such as learning and memory.78 While muscle insulin resistance increases 
risk of diabetes, it also allows the diversion of fuel to other tissues.76 
 
Leptin, secreted by adipose tissue, signals the magnitude of energy stores to the brain but 
also has broader functions, contributing to the regulation of reproduction, cognitive function 
and immune function.78-80 For example, leptin influences the functions of T-cells, monocytes, 
macrophages and natural killer cells, as well as the release and expression of cytokines and 
other inflammatory markers, while these molecules likewise contribute to the regulation of 
energy balance.80 While early linear growth benefits long-term health and human capital,81 
the association between low leptin and mortality in malnourished children indicates the 
short-term survival value of body fat.82 
 
Another influential hormone is cortisol, produced by the adrenal glands in response to 
diverse types of stress including illness, trauma, fear, pain and psychosocial stress. It too 
impacts diverse metabolic activities, for example suppressing immune function while 
increasing blood pressure and blood glucose.83  
 
In each case, therefore, these hormones implement the allocation of energy between life 
history functions. Whilst such plasticity may be adaptive, especially in the context of 
reproduction (see paper 3) it may also impose metabolic costs, accelerating the rate of aging 
(see Paper 4). Furthermore, human societies generate stresses for which their biology is 
unprepared or ‘mismatched’,84 such as pollutants, processed foods and sedentary 
environments.  
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Many trade-offs pertain to individual organisms. However, mammalian reproduction 
inherently brings the life history strategies of two generations together, through placental 
nutrition and lactation. This interaction may be characterized as a ‘tug-of-war’ over maternal 
metabolic resources,85 for the energy allocation ‘decisions’ optimal for maternal fitness may 
not be those that maximize offspring fitness. In such ‘parent-offspring conflict’ 
(Supplementary online Panel 1),86 the hormones reviewed above now function as signals 
between individuals, and each party can not only ‘read’ signals of the other, but also 
potentially manipulate them through their own hormonal secretions.87 The consequences of 
this ‘tug-of-war’ are expressed in several outcomes relevant to public health, including the 
prevalence of low birth weight, the incidence of colic, the duration of breast-feeding, and 
the management of infant sleep.87-89 The tug-of-war can itself be targeted by interventions, 
for example a randomized trial showed that promoting relaxation in breast-feeding mothers 
was associated with faster growth in their offspring.90  
 
Life history theory and behaviour 
 
Conventionally, public health models of behaviour emphasize ‘purpose’ and ‘individual 
autonomy’, in other words ‘how a person thinks rather than … what he or she does’,91 hence 
campaigns often target conscious deliberation. In contrast, life history theory makes 
predictions about behaviour itself, and makes no assumptions about whether decisions are 
made consciously or unconsciously. In other species, this question does not arise. Some 
conscious thought may simply provide post-hoc rationalization - more consequence of 
behaviour than cause.  
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Particularly in high-income low-fertility populations, contemporary behaviour is not 
maximizing fitness. This is partly because of cultural preferences (for wealth, social status, 
health, hedonic pleasure) that evolve independently of genes, and partly because of 
‘adaptive lag’ whereby environments change more rapidly than human biology.92 But we can 
still use evolutionary principles to understand associations between behaviour and health 
outcomes. 
 
In long-lived species such as humans, which produce offspring at regular intervals, the value 
of investing in somatic maintenance and future reproduction is expected to vary with 
ecological conditions. Higher extrinsic mortality risk favours diverting energy from 
maintenance to earlier reproductive effort. Why stint on reproduction if one is likely to die 
soon? Conversely, lower mortality risk favours higher investment in somatic maintenance, 
which may benefit future reproduction as well as longevity. Variation in mortality risk can 
therefore help explain both within- and between-population variation in behaviours relevant 
to public health, including reproductive ‘decisions’ and engagement in ‘risky’ behaviours 
(Supplementary online Panel 2).  
 
For example, reproductive timing varies in association with environmental harshness. In 
high-income countries, lower socio-economic position (SEP) correlates with earlier 
reproduction, and poorer health status may be an important explanatory variable. In 
England (2009-2011), living in areas with the highest deprivation (measured in deciles) was 
associated with 7 and 9 years shorter life expectancy for women and men respectively, 
compared with those in the least-deprived areas. Equivalent differences in healthy life 
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expectancy were twice as large.93 Early reproduction in low SEP women may therefore 
reflect both their lower expectancy of healthy life and the absence of benefits of waiting, for 
they typically have fewer opportunities to capitalize on educational and career opportunities. 
A link between deprivation and early age at first birth also holds across populations.94 
Greater energy investment in reproduction indicates lower investment in homeostasis 
(Panel 1), and may contribute to elevated NCD risk in low SEP populations.21 
 
In behavioural terms, lack of investment in self-preservation may be mediated by ‘time 
preferences’, where short-term gains are favoured over long-term rewards.95 For example, 
individuals unable to assume a long, healthy life lies ahead are expected to ‘discount the 
future’ and prioritize immediate rewards, whether through conscious or subconscious 
mechanisms (Supplementary online Panel 2). Individuals more oriented to the present 
report more risk-prone attitudes than those oriented to the future.96 However, the trade-off 
between longevity and reproduction can also be exploited for health benefit by 
interventions designed to appeal to personal ‘attractiveness’, as demonstrated for diet and 
cancer risk.97,98 
 
Extrinsic mortality risk therefore predicts many ‘unhealthy behaviours’ (smoking, drug 
consumption, poor diet, risky sexual behaviours) as well as lower commitment to healthy 
behaviours such as physical activity. Such unhealthy behaviours are consistently linked with 
lower SEP in high income countries,99 and this relationship appears to be mediated through 
higher perceptions of extrinsic mortality risk experienced by lower SEP individuals.100 Note 
that though such behaviours contribute to socio-economic health inequalities, they are not 
sufficient to entirely explain observed differences in life expectancy by SEP, indicating that 
 18 
structural and economic constraints are also important. Public health campaigns targeting 
such unhealthy behaviours might therefore have greater success if supported by efforts to 
reduce deprivation and increase access to health-care. Currently, however, medical 
treatment in some countries may be withheld from those who smoke or are obese. 
 
Mathematical modelling 
 
A strength of life history theory is that it can be expressed in terms of equations, enabling 
mathematical modelling. This may allow potential benefits and costs of interventions to be 
considered before their implementation in vivo. While models inevitably have limitations 
related to the assumptions involved, they may flag up in advance issues meriting more 
attention. While applicable to many contexts – e.g. predicting reaction norms or examining 
host-pathogen dynamics – they are particularly valuable for understanding parent-offspring 
dynamics, where life histories interact. 
 
To illustrate this we briefly consider the challenge of reducing child malnutrition, a major 
global health problem.101 Logic suggests a simple solution: increased energy supply. Since 
low birth weight contributes to subsequent malnutrition, logic also suggests that 
interventions should target pregnant mothers. Protein-energy supplementation 
programmes have thus been provided for pregnant mothers in several countries.102-104 
 
As the Ethiopian example demonstrated, however, mothers face a trade-off between 
investing in current versus potential future offspring.105 Additional energy might either 
support growth and survival of the former, or accelerate production of the latter. Assuming 
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that maternal metabolism has been selected to optimize lifetime reproductive fitness, 
models can predict the optimal energy allocation (Panel 3, Figure 3). Even simple models can 
clarify the issues and suggest qualitative predictions. 
 
Our model suggests that maternal supplementation can lead both to improved offspring 
survival and to a shorter period of dependency, increasing maternal fecundity. The balance 
between these effects, however, differs markedly according to the duration of the 
intervention. A short-term boost in resources promotes offspring growth and survival, 
whereas a long-term improvement primarily benefits maternal fecundity with little benefit 
for the size of individual offspring. 
 
The underlying reason is that mothers must balance the benefit of prolonged care for the 
current offspring against the risk that she will die and lose the opportunity to produce 
additional children. A short-term energy windfall increases the benefit of extending care for 
the current offspring, while leaving the mother’s long-term prospects unchanged. By 
contrast, a long-term improvement in resources increases the chances of future 
reproductive success, devaluing investment in the current offspring. Once again, this 
highlights how reproductive fitness may take priority over the health of individuals. 
 
The emerging field of evolutionary public health 
 
Life history theory improves understanding of human variability in disease susceptibility, and 
of how the organized efforts of societies to change behaviour or environments may impact 
health outcomes. Both physiology and behaviour respond to ecological stimuli through the 
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medium of trade-offs and reaction norms that favour survival and reproduction over health. 
Both physiology and behaviour have been selected to ‘discount the future’ in high-risk 
environments. One key insight is that we should not expect a given intervention to produce 
identical consequences in populations that contrast in resource availability and extrinsic 
mortality risk. 
 
This helps understand why poverty and deprivation have such powerful impacts on health 
and lifespan, and should themselves be a key target for interventions. Experience in early life 
may impact the entire trajectory of maturation and aging, generating trade-offs between 
reproduction and homeostasis.21 Consequently, programmes targeting individual behaviour 
might have greater health benefits if linked with broader efforts to combat poverty, 
deprivation and extrinsic mortality risks. Another key insight is that every individual 
phenotype reflects an accumulated history of trade-offs. This information could potentially 
improve the personalization of disease prevention, diagnosis and management. 
 
Evolutionary approaches are likely to be particularly valuable for addressing the challenges 
of global health, where populations are differentially exposed to multiple metabolic costs 
deriving from high fertility, diverse infectious diseases, and rapid changes in nutrition and 
lifestyle. Given such heterogeneity, mathematical modelling could be used to explore the 
likely costs and benefits of local interventions in silico, before their implementation in vivo. 
More broadly, evolutionary approaches offer a unique predictive framework with which to 
understand the basis of human disease and improve the efficacy of public health 
interventions. 
 
 21 
Contributors 
All authors wrote sections of this report, provided feedback on drafts, and approved the 
final version. 
 
Funding 
Preparation of this manuscript was facilitated by support of the Arizona State University 
Centre for Evolution and Medicine provided for an authors meeting. The model of growth 
was produced through a grant to RAJ and JCW from the Leverhulme Trust. 
 
   
 22 
Key messages 
What we know 
 Evolutionary theory is likely to improve the efficacy and integration of public health 
interventions, given its utility in other areas of public policy  
 Evolutionary life history theory is integrative, and can inform both physiological and 
behavioural components of public health interventions 
 Based on optimization principles, life history theory allows potential interventions to 
be modelled using mathematical techniques, identifying likely consequences before 
implementation in vivo  
 
What we need to know 
 How do predictions from life history theory change when populations occupy 
affluent and benign environments, and many individuals choose not to produce 
offspring? 
 How should we balance benefits versus costs that appear in different parts of the 
life-course, such as when interventions promoting early health affect long-term 
health adversely? 
 How can we integrate the insights generated by applying life history theory to 
plasticity into ‘personalized medicine’? 
 How can we use life history theory to improve public health campaigns promoting 
‘behaviour change’? 
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Panel 1. Life history theory predicts trade-offs relevant to public health 
 
 Immune function is metabolically costly, 106-108 and in children each degree 
temperature rise from fever increases metabolic rate by 11.3%,109 hence the costs of 
fighting infections impair child growth.110-113  
 This can account for epidemiological associations linking secular declines in infant 
mortality rate (a proxy for the energy costs of immune function in the survivors) with 
secular increases in adult height and longevity.114,115 Developmental exposure to 
infectious diseases shapes the entire life history strategy, and may propagate effects 
to subsequent generations. 116 
 Another key trade-off is between reproduction and longevity, with several studies 
showing that parental survivorship declined in proportion to the number of children 
produced, more strongly in mothers than fathers.117 However, the magnitude of this 
effect varies by living standards, and reproduction may protect against some cancers 
(see Paper 2).118,119  
 Such trade-offs also apply across generations: across 27 sub-Saharan African 
countries, the odds of child survival fell in relation to the number of offspring 
produced by the mother.120  
 Public health programmes targeting infant infections or adult reproduction are thus 
expected to shape long-term health outcomes and disease susceptibility through 
influencing these trade-offs. For example, nutritional interventions to resolve 
stunting may be ineffective unless also reducing the burden of infections and 
parasites.121 
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Panel 2. Reaction norms and the trade-offs that shape them 
 
 Maternal age and size at first birth vary with conditions encountered during growth 
and development. This plasticity maximizes the potential for reproductive success 
across the range of environments frequently encountered.  Life history theory 
predicts optimal reaction norms consistent with shifts caused by recent changes in 
nutrition and mortality risk. 
 Figure 2a distinguishes between the plastic developmental reaction to environmental 
change and the genetic evolution of that reaction (i.e. between nurture and nature).   
 The upper curve shows the optimal response to environmental improvement: the 
reproduction event slides up the reaction norm to the left, occurring earlier.  While 
this represents a developmental response, the shape and position of the reaction 
norm itself have evolved and are genetically determined.  
 The lower curve shows the evolution of that reaction norm.  Through demographic 
and epidemiological transition, infant mortality rates fell as public health and medical 
efforts decreased the impact of infectious disease.122,123  This drove the entire 
reaction norm down and to the left, resulting in a further decrease in age at first birth 
and a modest decrease in maternal size.   
 Why does the reaction norm change in this way? One major trade-off affecting 
human maturation relates infant mortality to maternal age (Figure 2b). As infant 
mortality declines, mothers are selected to have their first baby earlier.  
 Here, cultural evolution (improved health care) is interacting with biological 
evolution. It is important to understand that efforts of physicians and public health 
workers in the interest of promoting health may also shape human evolution itself.   
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Panel 3. An optimization model of maternal nutritional supplementation programmes 
 
 To assess the consequences of supplementing mothers to improve the growth of 
their offspring, we consider a mother producing single offspring sequentially.  
 The mother accrues resources (energy) to invest in offspring growth at a rate r per 
unit time. She is also exposed to a mortality risk m per unit time. The decision she 
faces is how long to support each offspring before producing the next. Longer 
support means more resources for the offspring, but greater risk the mother will die 
before the offspring reaches independence.  
 We assume that maternal death prior to independence leads to offspring death, 
whereas there is no risk of offspring death while the mother survives to care for it.  
 Following independence, the offspring survival depends upon the resources it 
received. We assume that some minimum level of resources is required for viability; 
beyond this, survival prospects increase with resources, but at an ever-diminishing 
rate (see supplementary online material).  
 Given these assumptions, we can determine the optimal duration of support that 
maximizes the mother’s expected lifetime fitness, and the resulting size and viability 
of her offspring (Figure 3). We can also ask how these outcomes change if we alter 
the level of resources available, either during the period of dependency of the 
current offspring, or throughout the remainder of the mother’s life. 
 The results show that whereas a short-term increase in maternal resources improves 
offspring growth and survival, a long-term increase in resource availability serves 
chiefly to promote greater fecundity in the mother, with little benefit for the size of 
individual offspring.  
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Figure 1. Schematic diagram illustrating life history trajectories across a fast-slow continuum. 
Fast life histories are favoured in environments with high mortality risk, while slow life 
histories can evolve when mortality risk reduces. These strategies may evolve under natural 
selection, but physiology can also respond to cues during the life-course through plasticity. 
The size of the circles is proportional to adult body size, and filled circles indicate individuals 
that survive to reproduce. 
 
Figure 2. (a) The reaction norm for the age at maturity in relation to body weight in adult 
females. In any population, the reaction norm allows variability in the response, but the 
norm itself can also evolve genetically over generations. Reproduced with permission from 
Stearns and Koella 1986.124 (b) The key trade-off that shapes the evolution of this reaction 
norm: the relationship between maternal age and infant mortality. Reproduced with 
permission from Stearns 1992.54 (See Panel 1).  
 
Figure 3. Results of a model predicting how maternal and offspring traits vary in accordance 
with ecological conditions, if the goal is to maximize maternal reproductive fitness. A short-
term intervention increasing energy availability increases maternal investment in the current 
offspring, leading to larger offspring size, and higher chance of offspring survival but has 
negligible effect on maternal fecundity. In contrast, the benefits of a long-term intervention 
are primarily captured by the mother through increased fecundity, whereas there is little 
effect on offspring investment, growth or chance of survival. 
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